Viromed Medical AG Cash Flow-to-Debt Ratio
Viromed Medical AG cash flow-to-debt ratio. Viromed Medical AG (Q11) has a Cash Flow-to-Debt Ratio of -0.14x as of September 2025, meaning its operating cash flow of €-10.12 Million could theoretically repay 0% of its total liabilities (€69.84 Million) in one year. See Viromed Medical AG (Q11) financial flexibility to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Viromed Medical AG (2021–2024)
Cash flow-to-debt ratio of Viromed Medical AG from 2021 to 2024. Historical debt coverage capacity for Viromed Medical AG across 4 annual periods. Check total reinvestment intensity of Viromed Medical AG to assess the company's total reinvestment commitment from operating cash flow.
Viromed Medical AG Cash Flow-to-Debt Ratio by Year (2021–2024)
Viromed Medical AG cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for Viromed Medical AG. For the full cash flow conversion analysis, see how efficiently does Viromed Medical AG generate cash.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | €-6.03 Million | €54.82 Million | ▲ +86.2% |
| 2023 | -0.80x | €-34.16 Million | €42.96 Million | ▲ +92.9% |
| 2022 | -11.17x | €-20.87 Million | €1.87 Million | ▼ -41.0% |
| 2021 | -7.92x | €-22.29 Million | €2.81 Million | — |